Cc1nn(Cc2ccccc2)c(Cl)c1/C=C/C(=O)OC(C(=O)NC(N)=O)C(C)C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?